OPIOID RECEPTOR MECHANISMS
OPIOID RECEPTOR MECHANISMS
批准号:
2116961
负责人:
FEDOR MEDZIHRADSKY
金额:
$16.4万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-01-01 至 1999-08-31
中文摘要
本文主要研究阿片受体的分子机制
英文摘要
This proposal focuses on the molecular mechanisms of opioid receptors in
intact neural cells and in the lipid environment of the plasma membrane.
One goal is to identify regulatory processes of opioid signal transduction
in a given cell in which multiple Opioid and non-opioid receptors function
concurrently, sharing thereby transducer and effector proteins ("cross-
talk"). This work will characterize those processes or components of
receptor signaling that will become rate-limiting in the concerted
environment of intact cells, and reveal mechanisms of receptor adaptation.
Applying multiple methodological approaches (including quantitation of
ligand-receptor-transducer-effector interactions, covalent protein
modification, use of antibodies and antisense oligonucleotides,
immunoblotting, receptor over-expression, cell membrane/liposome
fusion/reconstitution with purified protein components, enzyme assays, ion
transport), the selectivity, stoichiometry and regulation of coupling of
mu and delta opioid receptors to type-specific adenylyl cyclase and Ca2+-
channels through G protein subtypes will be assessed, including the role
of cAMP-dependent protein kinase. Subsequently, the mutual modulation
between the two opioid and an opioid and inhibitory adrenergic and
muscarinic receptor systems will be studied in cells in which the
concentration/availability of receptor/transducer/effector is selectively
altered to induce adaptation. To understand the significance of trophic
factors and of cell-to-cell communication occurring in brain, opioid
signal transduction will also be studied under conditions of neuron-glia
interaction in vitro, and in cells in which receptor function is
influenced by differentiating agents. In neural cells exhibiting
biochemical correlates (cAMP levels) of opioid tolerance and dependence,
the regulation of receptor and of selective G protein content and
coupling, and the role Of G protein selectivity will be evaluated. In
conjunction, the contribution of receptor reserve and of receptor-G
protein coupling to agonist potency and efficacy in eliciting an effector
response (adenylyl cyclase, Ca2+ transport) will be assessed. Within the
overall focus on regulation by molecular cross-talk, the other goal is to
characterize the mechanisms underlying the potent modulation o opioid
receptor function (conformation, binding affinity/capacity, membrane
dynamics) by membrane lipids and by the biophysical property of the
membrane environment. Using lipid transfer proteins and fusion techniques
for membrane modification, fluorescent opioids and G proteins, and
fluorescent techniques of high sensitivity and resolution (time-resolved
fluorescence and fluorescence recovery after photobleaching), the
functionally essential lipid boundary layer around opioid receptors will
be identified, the mobility of receptor and G protein in the plasma
membrane determined and its role in the regulation of opioid signal
transduction assessed (collision-coupling mechanism). In summary, the
proposed research describes the use of advanced approaches of
biochemistry, pharmacology, and neuroscience to elucidate the regulation
of opioid function at the molecular, membrane, and cellular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:6332477
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:6300700
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:6201557
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1999
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:6103885
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:6237829
-
项目类别:
-
资助金额:$15.42万
-
财政年份:1997
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR-LIPID INTERACTIONS IN NEURAL MEMBRANES
-
批准号:3023510
-
项目类别:
-
资助金额:$2.32万
-
财政年份:1993
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:3209150
-
项目类别:
-
资助金额:$17.14万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:3209155
-
项目类别:
-
资助金额:$18.29万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:3209156
-
项目类别:
-
资助金额:$19.35万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:3209157
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:2517883
-
项目类别:
-
资助金额:$17.79万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIOID RECEPTOR MECHANISMS
-
批准号:2012863
-
项目类别:
-
资助金额:$17.1万
-
财政年份:1990
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIATE RECEPTOR MECHANISMS
-
批准号:3209153
-
项目类别:
-
资助金额:$13.9万
-
财政年份:1987
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIATE RECEPTOR MECHANISMS
-
批准号:3209154
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1987
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
OPIATE RECEPTOR MECHANISMS
-
批准号:3209149
-
项目类别:
-
资助金额:$13.36万
-
财政年份:1987
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:
IN VITRO PHARMACOLOGY OF OPIOIDS
-
批准号:5209598
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:FEDOR MEDZIHRADSKY
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
-
批准号:81903932
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:龚陈媛
-
依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
-
批准号:81970025
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:高金明
-
依托单位:
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
-
批准号:31872970
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:李斌
-
依托单位:
衰老过程中Lamin-B Receptor蛋白聚积通过扰乱干细胞竞争促进生殖干细胞丢失的分子机制研究
-
批准号:31671254
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2016
-
负责人:陈海洋
-
依托单位:
Leptin Receptor负向调控应力刺激诱导的后纵韧带骨化的分子机制及转化研究
-
批准号:81401821
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:陈剑
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
受体相互作用蛋白3(Receptor-interacting protein 3,RIP3)调控神经元缺血性程序性坏死的作用及机制研究
-
批准号:81271272
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:罗本燕
-
依托单位:
Retinoid X Receptor(RXR)α启动子甲基化在结直肠癌发生发展中的作用
-
批准号:81201582
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:张芬芬
-
依托单位: